Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Functional segregation in Parkinson's disease.

Science advances·2026

Same author

Age-related changes to brain energetics revealed by PET/MRI imaging.

NeuroImage. Clinical·2026

Same author

Exercise-Induced modulation of molecular-enriched functional connectivity in Parkinson's disease.

Journal of Parkinson's disease·2026

Same author

Movement Disorders Thanks Journal Reviewers from 2025.

Movement disorders : official journal of the Movement Disorder Society·2026

Same author

The Journal at Forty: A Proud Legacy and a Look to the Future.

Movement disorders : official journal of the Movement Disorder Society·2026

Same author

Novel insights into relationships between metabolic covariance patterns of FDG-PET data and clinical status in Parkinson's disease using partial least squares correlation analysis.

Journal of Parkinson's disease·2025

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

Visualizing vesicular dopamine dynamics in Parkinson's disease.

Raúl de la Fuente-Fernández¹, Vesna Sossi, Siobhan McCormick

¹Pacific Parkinson's Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.

Synapse (New York, N.Y.)

|April 25, 2009

Summary

Levodopa in Parkinson's disease (PD) appears to enter dopamine vesicles, similar to naturally produced dopamine. This study used a novel PET imaging technique to track vesicular dopamine levels after levodopa administration in PD patients.

More Related Videos

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Related Experiment Videos

Last Updated: Jun 23, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Area of Science:

Neuroscience
Pharmacology
Medical Imaging

Background:

Parkinson's disease (PD) is characterized by dopamine deficiency.
Levodopa is a primary treatment, but its precise intracellular handling is debated.
It's unclear if levodopa-derived dopamine integrates into vesicular storage mechanisms.

Purpose of the Study:

To investigate whether dopamine derived from exogenous levodopa follows normal vesicular dynamics in Parkinson's disease.
To assess changes in vesicular dopamine levels after levodopa administration using PET imaging.

Main Methods:

Utilized a novel Positron Emission Tomography (PET) method.
Employed [(11)C]-dihydrotetrabenazine (DTBZ) as a tracer, sensitive to vesicular dopamine levels.
Measured changes in striatal [(11)C]-DTBZ binding before and after levodopa administration in advanced PD patients.

Main Results:

Striatal [(11)C]-DTBZ binding significantly decreased following levodopa administration.
This reduction suggests an increase in vesicular dopamine levels.
Indicates that levodopa-derived dopamine is taken up into vesicles.

Conclusions:

Exogenously administered levodopa-derived dopamine appears to follow the same vesicular dynamics as endogenous dopamine in Parkinson's disease.
Supports the model where levodopa effectively replenishes vesicular dopamine stores.
Provides in vivo evidence for the integration of levodopa-derived dopamine into presynaptic terminals.